91 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
recommendations in renal ... hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... Dosing #Dosing #Renal
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... pharmacology #dm2 #diabetes ... #medications #overview ... #management #comparison
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... Each class of medications ... #diabetes #endocrinology ... #treatment
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... pregabalin as treatment ... Peripheral #Neuropathy #Diabetes ... Pharmacology #Management #Medications
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
Used to Treat Diabetes ... #Diabetes #Pharmacology ... #Comparison #Table ... #Medications #Noninsulin
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... in type 2 diabetes ... Canagliflozin on Renal ... Diabetes Care 2018 ... Diabetes Care 19
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... monitors in Type 1 Diabetes ... insulin dose for renal ... pocketcardset #Diabetes
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... EricsMedicalLectures/featured #diabetes ... #medications #table ... #comparison #management
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and renal ... effects comparison ... (Steglatro) #diabetes ... cardiovascular #renal
Diabetic Ketoacidosis 
Management Priorities
1. Fluids 
2. Insulin 
3. Potassium 
4. Acidosis 
5. Re-establish oral fluids,
Diabetic Ketoacidosis ... Fluids 2. ... Identification and treatment ... cause #DKA #Diabetic ... #Ketoacidosis #Diabetes